Transition - Revision history

InternetArchiveBot: Rescuing 3 sources and tagging 0 as dead.) #IABot (v2.0.9.5

2023-11-28T03:46:34Z

Rescuing 3 sources and tagging 0 as dead.) #IABot (v2.0.9.5

← Older revision		Revision as of 03:46, 28 November 2023
Line 36:		Line 36:

	<!--T:14-->		<!--T:14-->
	Historically, eligibility criteria for medical treatment has presented a barrier for nonbinary individuals, specifically the 'real life test' (RLT) component which was later renamed the 'real life experience' (RLE). The website of the London NHS gender identity clinic states, ''"There is a two year Real Life Experience (RLE) of living in the reassigned gender role at the GIC for people who want to have genital reconstruction surgery (GRS). This is dated from the start of full-time gender role transition after which they can be assessed for referral for GRS. The RLE includes at least a year in some form of agreed occupational activities."'' [https://web.archive.org/web/20140901175724/http://www.wlmht.nhs.uk/gi/gender-identity-clinic/frequently-asked-questions/]. Nonbinary individuals requesting genital reconstruction surgery (GRS) are generally unable to satisfy clinicians in relation to the RLE criteria as there is little [http://nonbinary.org/wiki/Recognition_~~%28UK%29~~ social] or [http://nonbinary.org/wiki/Legal_gender#UK legal recognition] of the nonbinary demographic. On the 1st December 2010, the University of Cambridge Centre for Gender Studies hosted the final public forum in its series on gender and radical biomedical advances, ''“Transitioning gender: the challenges of radical technologies”'', in association with the Guardian and supported by Cambridge University Press [http://www.guardian.co.uk/commentisfree/audio/2010/dec/07/transitioning-gender-radical-technologies-debate]. One of the speakers was Dr Richard Green, former research director and consultant psychiatrist of the London NHS gender identity clinic, who referenced ''“third gender or no-gender person(s)”'' seeking surgery to ''“remove breasts or male genitalia”'' and calls this a ''“medical '''dilemma for physicians because there’s no real life experience'''. Its either surgery, or not”''.		Historically, eligibility criteria for medical treatment has presented a barrier for nonbinary individuals, specifically the 'real life test' (RLT) component which was later renamed the 'real life experience' (RLE). The website of the London NHS gender identity clinic states, ''"There is a two year Real Life Experience (RLE) of living in the reassigned gender role at the GIC for people who want to have genital reconstruction surgery (GRS). This is dated from the start of full-time gender role transition after which they can be assessed for referral for GRS. The RLE includes at least a year in some form of agreed occupational activities."'' [https://web.archive.org/web/20140901175724/http://www.wlmht.nhs.uk/gi/gender-identity-clinic/frequently-asked-questions/]. Nonbinary individuals requesting genital reconstruction surgery (GRS) are generally unable to satisfy clinicians in relation to the RLE criteria as there is little [https://web.archive.org/web/20161209151923/http://nonbinary.org/wiki/Recognition_(UK) social] or [https://web.archive.org/web/20170209083236/http://nonbinary.org/wiki/Legal_gender#UK legal recognition] of the nonbinary demographic. On the 1st December 2010, the University of Cambridge Centre for Gender Studies hosted the final public forum in its series on gender and radical biomedical advances, ''“Transitioning gender: the challenges of radical technologies”'', in association with the Guardian and supported by Cambridge University Press [http://www.guardian.co.uk/commentisfree/audio/2010/dec/07/transitioning-gender-radical-technologies-debate]. One of the speakers was Dr Richard Green, former research director and consultant psychiatrist of the London NHS gender identity clinic, who referenced ''“third gender or no-gender person(s)”'' seeking surgery to ''“remove breasts or male genitalia”'' and calls this a ''“medical '''dilemma for physicians because there’s no real life experience'''. Its either surgery, or not”''.

	<!--T:15-->		<!--T:15-->
Line 79:		Line 79:

	<!--T:30-->		<!--T:30-->
	: ''Main article: [http://nonbinary.org/wiki/Nonbinary#Nonbinary_presentation_and_expression Nonbinary presentation and expression]''		: ''Main article: [https://web.archive.org/web/20170129205539/http://nonbinary.org/wiki/Nonbinary#Nonbinary_presentation_and_expression Nonbinary presentation and expression]''

	<!--T:31-->		<!--T:31-->

InternetArchiveBot: Rescuing 2 sources and tagging 0 as dead.) #IABot (v2.0.9.5

2023-07-28T03:34:26Z

Rescuing 2 sources and tagging 0 as dead.) #IABot (v2.0.9.5

← Older revision		Revision as of 03:34, 28 July 2023
Line 36:		Line 36:

	<!--T:14-->		<!--T:14-->
	Historically, eligibility criteria for medical treatment has presented a barrier for nonbinary individuals, specifically the 'real life test' (RLT) component which was later renamed the 'real life experience' (RLE). The website of the London NHS gender identity clinic states, ''"There is a two year Real Life Experience (RLE) of living in the reassigned gender role at the GIC for people who want to have genital reconstruction surgery (GRS). This is dated from the start of full-time gender role transition after which they can be assessed for referral for GRS. The RLE includes at least a year in some form of agreed occupational activities."'' [http://www.wlmht.nhs.uk/gi/gender-identity-clinic/frequently-asked-questions/]. Nonbinary individuals requesting genital reconstruction surgery (GRS) are generally unable to satisfy clinicians in relation to the RLE criteria as there is little [http://nonbinary.org/wiki/Recognition_%28UK%29 social] or [http://nonbinary.org/wiki/Legal_gender#UK legal recognition] of the nonbinary demographic. On the 1st December 2010, the University of Cambridge Centre for Gender Studies hosted the final public forum in its series on gender and radical biomedical advances, ''“Transitioning gender: the challenges of radical technologies”'', in association with the Guardian and supported by Cambridge University Press [http://www.guardian.co.uk/commentisfree/audio/2010/dec/07/transitioning-gender-radical-technologies-debate]. One of the speakers was Dr Richard Green, former research director and consultant psychiatrist of the London NHS gender identity clinic, who referenced ''“third gender or no-gender person(s)”'' seeking surgery to ''“remove breasts or male genitalia”'' and calls this a ''“medical '''dilemma for physicians because there’s no real life experience'''. Its either surgery, or not”''.		Historically, eligibility criteria for medical treatment has presented a barrier for nonbinary individuals, specifically the 'real life test' (RLT) component which was later renamed the 'real life experience' (RLE). The website of the London NHS gender identity clinic states, ''"There is a two year Real Life Experience (RLE) of living in the reassigned gender role at the GIC for people who want to have genital reconstruction surgery (GRS). This is dated from the start of full-time gender role transition after which they can be assessed for referral for GRS. The RLE includes at least a year in some form of agreed occupational activities."'' [https://web.archive.org/web/20140901175724/http://www.wlmht.nhs.uk/gi/gender-identity-clinic/frequently-asked-questions/]. Nonbinary individuals requesting genital reconstruction surgery (GRS) are generally unable to satisfy clinicians in relation to the RLE criteria as there is little [http://nonbinary.org/wiki/Recognition_%28UK%29 social] or [http://nonbinary.org/wiki/Legal_gender#UK legal recognition] of the nonbinary demographic. On the 1st December 2010, the University of Cambridge Centre for Gender Studies hosted the final public forum in its series on gender and radical biomedical advances, ''“Transitioning gender: the challenges of radical technologies”'', in association with the Guardian and supported by Cambridge University Press [http://www.guardian.co.uk/commentisfree/audio/2010/dec/07/transitioning-gender-radical-technologies-debate]. One of the speakers was Dr Richard Green, former research director and consultant psychiatrist of the London NHS gender identity clinic, who referenced ''“third gender or no-gender person(s)”'' seeking surgery to ''“remove breasts or male genitalia”'' and calls this a ''“medical '''dilemma for physicians because there’s no real life experience'''. Its either surgery, or not”''.

	<!--T:15-->		<!--T:15-->
Line 240:		Line 240:

	==External links and further reading== <!--T:88-->		==External links and further reading== <!--T:88-->
	* [http://openmindedhealth.com/transgender-101-trans-people Trans 101 for Trans People] has a nearly comprehensive list of physical transition options for trans people of all kinds, with lots of information about each.		* [https://web.archive.org/web/20170730063826/http://openmindedhealth.com/transgender-101-trans-people/ Trans 101 for Trans People] has a nearly comprehensive list of physical transition options for trans people of all kinds, with lots of information about each.

	==References== <!--T:89-->		==References== <!--T:89-->

BinaryBot: Bot: adding archive links to references (error log).

2023-07-17T15:55:38Z

Bot: adding archive links to references (error log).

← Older revision		Revision as of 15:55, 17 July 2023
Line 39:		Line 39:

	<!--T:15-->		<!--T:15-->
	''“...Young people are eligible for treatment in the adult NHS clinics (once they are 18 years old) or by private practitioners (from 16 years old)”'' <ref>http://www.gires.org.uk/assets/DOH-Assets/pdf/doh-children-and-adolescents.pdf</ref>.		''“...Young people are eligible for treatment in the adult NHS clinics (once they are 18 years old) or by private practitioners (from 16 years old)”'' <ref>http://www.gires.org.uk/assets/DOH-Assets/pdf/doh-children-and-adolescents.pdf [https://web.archive.org/web/20230310110222/http://www.gires.org.uk/assets/DOH-Assets/pdf/doh-children-and-adolescents.pdf Archived] on 17 July 2023</ref>.

	==Changing your name== <!--T:16-->		==Changing your name== <!--T:16-->
Line 55:		Line 55:

	<!--T:21-->		<!--T:21-->
	Changing one's name within an everyday social context can be as simple as informing others of one's choice. However, in societies with a complex legal system (or equivalent), there can be conditions that place limitations on the individual's right to self determination, which can be especially problematic for [[nonbinary]] individuals. For example, in Germany the Standesamt (Office of Vital Statistics) <ref>http://standesamtauskunft.de/Default2.aspx</ref> typically refuses to recognise in German civil registration law names that are gender-ambiguous; a given name must indicate that the owner is either 'male' or 'female'.		Changing one's name within an everyday social context can be as simple as informing others of one's choice. However, in societies with a complex legal system (or equivalent), there can be conditions that place limitations on the individual's right to self determination, which can be especially problematic for [[nonbinary]] individuals. For example, in Germany the Standesamt (Office of Vital Statistics) <ref>http://standesamtauskunft.de/Default2.aspx [https://web.archive.org/web/20210920205748/https://standesamtauskunft.de/Default2.aspx Archived] on 17 July 2023</ref> typically refuses to recognise in German civil registration law names that are gender-ambiguous; a given name must indicate that the owner is either 'male' or 'female'.

	=====State of Address===== <!--T:22-->		=====State of Address===== <!--T:22-->
Line 109:		Line 109:

	<!--T:92-->		<!--T:92-->
	Puberty blockers are drugs that postpone or temporarily suspend puberty in children and teenagers. They are used for [[transgender]] children, including those who identify as [[nonbinary]], to stop the development of features that they consider to mark the wrong sex,<ref name=":0">{{Cite journal\|last=Stevens\|first=Jaime\|last2=Gomez-Lobo\|first2=Veronica\|last3=Pine-Twaddell\|first3=Elyse\|date=2015-12-01\|title=Insurance Coverage of Puberty Blocker Therapies for Transgender Youth\|url=http://pediatrics.aappublications.org/content/136/6/1029\|journal=Pediatrics\|language=en\|volume=136\|issue=6\|pages=1029–1031\|doi=10.1542/peds.2015-2849\|issn=0031-4005\|pmid=26527547\|doi-access=free}}</ref><ref>{{cite web \|url=http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ \|title=Looking at suppressing puberty for transgender kids \|publisher=Associated Press \|date=March 12, 2016}}</ref><ref>{{cite web \|url=https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ \|title=Transgender Youth Using Puberty Blockers \|publisher=[[KQED]] \|date=August 19, 2016}}</ref> with the intent to provide transgender youth more time to explore their identity.<ref name=":1">{{Cite journal\|last=Alegría\|first=Christine Aramburu\|date=2016-10-01\|title=Gender nonconforming and transgender children/youth: Family, community, and implications for practice\|journal=Journal of the American Association of Nurse Practitioners\|language=en\|volume=28\|issue=10\|pages=521–527\|doi= 10.1002/2327-6924.12363\|pmid=27031444\|issn=2327-6924}}</ref> the studies that have been conducted indicate that these treatments are reasonably safe, and can improve psychological well-being in these individuals.<ref name="lancet_pubertyblockers">{{cite journal \| last=Mahfouda \| first=Simone \| last2=Moore \| first2=Julia K \| last3=Siafarikas \| first3=Aris \| last4=Zepf \| first4=Florian D \| last5=Lin \| first5=Ashleigh \| title=Puberty suppression in transgender children and adolescents \| journal=The Lancet Diabetes & Endocrinology \| publisher=Elsevier BV \| volume=5 \| issue=10 \| year=2017 \| issn=2213-8587 \| doi=10.1016/s2213-8587(17)30099-2 \| pmid=28546095 \| pages=816–826 \| ref=harv\|quote=The few studies that have examined the psychological effects of suppressing puberty, as the first stage before possible future commencement of CSH therapy, have shown benefits."}}</ref><ref>{{cite journal \|last1=Rafferty \|first1=Jason \|title=Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents \|journal=Pediatrics \|date=October 2018 \|volume=142 \|issue=4 \|pages=e20182162 \|url=https://pediatrics.aappublications.org/content/142/4/e20182162 \|accessdate=23 July 2019\|quote=Often, pubertal suppression...reduces the need for later surgery because physical changes that are otherwise irreversible (protrusion of the Adam’s apple, male pattern baldness, voice change, breast growth, etc) are prevented. The available data reveal that pubertal suppression in children who identify as TGD generally leads to improved psychological functioning in adolescence and young adulthood.\|doi=10.1542/peds.2018-2162 \|pmid=30224363 \|doi-access=free }}</ref><ref name="Hembree_et_al">{{cite journal \|last1=Hembree \|first1=Wylie C \|last2=Cohen-Kettenis \|first2=Peggy T \|last3=Gooren \|first3=Louis \|last4=Hannema \|first4=Sabine E \|last5=Meyer \|first5=Walter J \|last6=Murad \|first6=M Hassan \|last7=Rosenthal \|first7=Stephen M \|last8=Safer \|first8=Joshua D \|last9=Tangpricha \|first9=Vin \|last10=T'Sjoen \|first10=Guy G \|title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline \|journal=The Journal of Clinical Endocrinology & Metabolism \|date=November 2017 \|volume=102 \|issue=11 \|page=3881\|quote=Treating GD/gender-incongruent adolescents entering puberty with GnRH analogs has been shown to improve psychological functioning in several domains\|doi=10.1210/jc.2017-01658 \|pmid=28945902 \|doi-access=free }}</ref> In 2019, a study in the journal ''Pediatrics'' found that access to pubertal suppression during adolescence was associated with a lower odds of lifetime suicidality among transgender people.<ref>{{cite journal \|last1=Turban \|first1=Jack \|title=Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation \|journal=Pediatrics \|date=February 2020 \|volume=145 \|issue=2 \|page=e2019172 \|doi=10.1542/peds.2019-1725 \|pmid=31974216 \|url=https://pediatrics.aappublications.org/content/145/2/e20191725 \|accessdate=11 February 2020\|pmc=7073269 }}</ref>		Puberty blockers are drugs that postpone or temporarily suspend puberty in children and teenagers. They are used for [[transgender]] children, including those who identify as [[nonbinary]], to stop the development of features that they consider to mark the wrong sex,<ref name=":0">{{Cite journal\|last=Stevens\|first=Jaime\|last2=Gomez-Lobo\|first2=Veronica\|last3=Pine-Twaddell\|first3=Elyse\|date=2015-12-01\|title=Insurance Coverage of Puberty Blocker Therapies for Transgender Youth\|url=http://pediatrics.aappublications.org/content/136/6/1029\|journal=Pediatrics\|language=en\|volume=136\|issue=6\|pages=1029–1031\|doi=10.1542/peds.2015-2849\|issn=0031-4005\|pmid=26527547\|doi-access=free\|archive-url=https://web.archive.org/web/20230628170532/http://pediatrics.aappublications.org/content/136/6/1029\|archive-date=17 July 2023}}</ref><ref>{{cite web \|url=http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ \|title=Looking at suppressing puberty for transgender kids \|publisher=Associated Press \|date=March 12, 2016\|archive-url=https://web.archive.org/web/20230617205749/http://www.washingtontimes.com/news/2016/mar/12/looking-at-suppressing-puberty-for-transgender-kid/ \|archive-date=17 July 2023 }}</ref><ref>{{cite web \|url=https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ \|title=Transgender Youth Using Puberty Blockers \|publisher=[[KQED]] \|date=August 19, 2016\|archive-url=https://web.archive.org/web/20221211205947/https://ww2.kqed.org/futureofyou/2016/08/19/transgender-youth-using-puberty-blockers/ \|archive-date=17 July 2023 }}</ref> with the intent to provide transgender youth more time to explore their identity.<ref name=":1">{{Cite journal\|last=Alegría\|first=Christine Aramburu\|date=2016-10-01\|title=Gender nonconforming and transgender children/youth: Family, community, and implications for practice\|journal=Journal of the American Association of Nurse Practitioners\|language=en\|volume=28\|issue=10\|pages=521–527\|doi= 10.1002/2327-6924.12363\|pmid=27031444\|issn=2327-6924}}</ref> the studies that have been conducted indicate that these treatments are reasonably safe, and can improve psychological well-being in these individuals.<ref name="lancet_pubertyblockers">{{cite journal \| last=Mahfouda \| first=Simone \| last2=Moore \| first2=Julia K \| last3=Siafarikas \| first3=Aris \| last4=Zepf \| first4=Florian D \| last5=Lin \| first5=Ashleigh \| title=Puberty suppression in transgender children and adolescents \| journal=The Lancet Diabetes & Endocrinology \| publisher=Elsevier BV \| volume=5 \| issue=10 \| year=2017 \| issn=2213-8587 \| doi=10.1016/s2213-8587(17)30099-2 \| pmid=28546095 \| pages=816–826 \| ref=harv\|quote=The few studies that have examined the psychological effects of suppressing puberty, as the first stage before possible future commencement of CSH therapy, have shown benefits."}}</ref><ref>{{cite journal \|last1=Rafferty \|first1=Jason \|title=Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents \|journal=Pediatrics \|date=October 2018 \|volume=142 \|issue=4 \|pages=e20182162 \|url=https://pediatrics.aappublications.org/content/142/4/e20182162 \|accessdate=23 July 2019\|quote=Often, pubertal suppression...reduces the need for later surgery because physical changes that are otherwise irreversible (protrusion of the Adam’s apple, male pattern baldness, voice change, breast growth, etc) are prevented. The available data reveal that pubertal suppression in children who identify as TGD generally leads to improved psychological functioning in adolescence and young adulthood.\|doi=10.1542/peds.2018-2162 \|pmid=30224363 \|doi-access=free \|archive-url=https://web.archive.org/web/20230614175518/https://pediatrics.aappublications.org/content/142/4/e20182162 \|archive-date=17 July 2023 }}</ref><ref name="Hembree_et_al">{{cite journal \|last1=Hembree \|first1=Wylie C \|last2=Cohen-Kettenis \|first2=Peggy T \|last3=Gooren \|first3=Louis \|last4=Hannema \|first4=Sabine E \|last5=Meyer \|first5=Walter J \|last6=Murad \|first6=M Hassan \|last7=Rosenthal \|first7=Stephen M \|last8=Safer \|first8=Joshua D \|last9=Tangpricha \|first9=Vin \|last10=T'Sjoen \|first10=Guy G \|title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline \|journal=The Journal of Clinical Endocrinology & Metabolism \|date=November 2017 \|volume=102 \|issue=11 \|page=3881\|quote=Treating GD/gender-incongruent adolescents entering puberty with GnRH analogs has been shown to improve psychological functioning in several domains\|doi=10.1210/jc.2017-01658 \|pmid=28945902 \|doi-access=free }}</ref> In 2019, a study in the journal ''Pediatrics'' found that access to pubertal suppression during adolescence was associated with a lower odds of lifetime suicidality among transgender people.<ref>{{cite journal \|last1=Turban \|first1=Jack \|title=Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation \|journal=Pediatrics \|date=February 2020 \|volume=145 \|issue=2 \|page=e2019172 \|doi=10.1542/peds.2019-1725 \|pmid=31974216 \|url=https://pediatrics.aappublications.org/content/145/2/e20191725 \|accessdate=11 February 2020\|pmc=7073269 \|archive-url=https://web.archive.org/web/20230604181439/https://pediatrics.aappublications.org/content/145/2/e20191725 \|archive-date=17 July 2023 }}</ref>

	===Change your voice=== <!--T:33-->		===Change your voice=== <!--T:33-->
Line 182:		Line 182:

	<!--T:113-->		<!--T:113-->
	Periods are often a source of distressing [[gender dysphoria]] for nonbinary people who were [[sexes#assigned female at birth\|assigned female at birth]]. There are several ways of preventing periods:<ref>{{Cite journal\|last=Carswell\|first=Jeremi M.\|last2=Roberts\|first2=Stephanie A.\|date=December 2017\|title=Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents\|url=http://www.liebertpub.com/doi/10.1089/trgh.2017.0021\|journal=Transgender Health\|language=en\|volume=2\|issue=1\|pages=195–201\|doi=10.1089/trgh.2017.0021\|issn=2380-193X\|pmc=PMC5684657\|pmid=29142910}}</ref>		Periods are often a source of distressing [[gender dysphoria]] for nonbinary people who were [[sexes#assigned female at birth\|assigned female at birth]]. There are several ways of preventing periods:<ref>{{Cite journal\|last=Carswell\|first=Jeremi M.\|last2=Roberts\|first2=Stephanie A.\|date=December 2017\|title=Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents\|url=http://www.liebertpub.com/doi/10.1089/trgh.2017.0021\|journal=Transgender Health\|language=en\|volume=2\|issue=1\|pages=195–201\|doi=10.1089/trgh.2017.0021\|issn=2380-193X\|pmc=PMC5684657\|pmid=29142910\|archive-url=https://web.archive.org/web/20230410073008/https://www.liebertpub.com/doi/10.1089/trgh.2017.0021\|archive-date=17 July 2023}}</ref>
	* [[Transmasculine hormone therapy]], such as [[Testosterone]]: Testosterone will prevent periods (although the changes won't be immediate).		* [[Transmasculine hormone therapy]], such as [[Testosterone]]: Testosterone will prevent periods (although the changes won't be immediate).
	* [[Progestogens]], such as birth control pills: these will also prevent (or, at least, decrease) periods, although they are not as effective as testosterone. However, they won't cause masculinisation.		* [[Progestogens]], such as birth control pills: these will also prevent (or, at least, decrease) periods, although they are not as effective as testosterone. However, they won't cause masculinisation.

184.71.74.66: /* Hormone therapy to seem androgynous */

2022-11-26T03:16:50Z

Hormone therapy to seem androgynous

← Older revision		Revision as of 03:16, 26 November 2022
Line 219:		Line 219:

	<!--T:125-->		<!--T:125-->
	Some nonbinary people want to look and sound in such a way that most people can't categorize them as a man or a woman. There is no one widely recognized hormone therapy for this. Possible options for people who want to suppress both masculinizing and femininizing hormones at the same time are described in the [https://madgenderscience.miraheze.org/wiki/Experimental_non-binary_HRT#Sex-hormone_antagonists_alone Mad Gender Science Wiki].		Some nonbinary people want to look and sound in such a way that most people can't categorize them as a man or a woman. There is no one widely recognized hormone therapy for this but one viable way would be a combination of raising testosterone while on estrogen. Possible (but medically considered highly dangerous and/or unsafe) options for people who want to suppress both masculinizing and femininizing hormones at the same time are described in the [https://madgenderscience.miraheze.org/wiki/Experimental_non-binary_HRT#Sex-hormone_antagonists_alone Mad Gender Science Wiki].

	===Changing the genitals and reproductive organs=== <!--T:126-->		===Changing the genitals and reproductive organs=== <!--T:126-->

Ondo: Marked this version for translation

2022-04-08T20:13:53Z

Marked this version for translation

Show changes

Ondo at 20:13, 8 April 2022

2022-04-08T20:13:38Z

← Older revision		Revision as of 20:13, 8 April 2022
Line 213:		Line 213:
	*''[[Practical resources]]'' for a list of related topics not covered in this article, such as [[coming out]], relationships, [[intimacy]], etc.		*''[[Practical resources]]'' for a list of related topics not covered in this article, such as [[coming out]], relationships, [[intimacy]], etc.

	==External links and further reading== <!--T:45-->		==External links and further reading== <!--T:88-->
	* [http://openmindedhealth.com/transgender-101-trans-people Trans 101 for Trans People] has a nearly comprehensive list of physical transition options for trans people of all kinds, with lots of information about each.		* [http://openmindedhealth.com/transgender-101-trans-people Trans 101 for Trans People] has a nearly comprehensive list of physical transition options for trans people of all kinds, with lots of information about each.

	==References== <!--T:46-->		==References== <!--T:89-->
	</translate>		</translate>
	<references />		<references />

Amazingakita: Reverted edits by 75.27.37.89 (talk) to last revision by 2A02:2454:A2:E900:9C8C:3886:2E15:3204

2021-12-10T23:05:13Z

Reverted edits by 75.27.37.89 (talk) to last revision by 2A02:2454:A2:E900:9C8C:3886:2E15:3204

Show changes

75.27.37.89: Replaced content with "Category:Transition Category:Gender expression Category:Concepts de:transition Libtards are morans and their to stuped to except any fact that dosent sapport there narritave cause they dont no anything mabey you should of lisened in school and not mist class than you mite not be so dum your a discrase to are country get a bran loosers your so stuped weather you no it or not your litorally dummer then a bag of bricks your rediculous you have no sence..."

2021-12-10T23:00:15Z

Replaced content with "Category:Transition Category:Gender expression Category:Concepts de:transition Libtards are morans and their to stuped to except any fact that dosent sapport there narritave cause they dont no anything mabey you should of lisened in school and not mist class than you mite not be so dum your a discrase to are country get a bran loosers your so stuped weather you no it or not your litorally dummer then a bag of bricks your rediculous you have no sence..."

Show changes

2A02:2454:A2:E900:9C8C:3886:2E15:3204: made a few grammatical improvements

2021-07-16T17:21:26Z

made a few grammatical improvements

← Older revision		Revision as of 17:21, 16 July 2021
Line 55:		Line 55:

	<!--T:21-->		<!--T:21-->
	Changing ~~ones~~ name within an everyday social context can be as simple as informing others of ~~your~~ choice, ~~however~~ in societies with a complex legal system (or equivalent) there can be conditions that place limitations on the ~~individuals~~ right to self determination which can be especially problematic for [[nonbinary]] individuals. For example, in Germany the Standesamt (Office of Vital Statistics) <ref>http://standesamtauskunft.de/Default2.aspx</ref> typically refuses to recognise in German civil registration law names that are gender-ambiguous; a given name must indicate that the owner is either 'male' or 'female'.		Changing one's name within an everyday social context can be as simple as informing others of one's choice. However, in societies with a complex legal system (or equivalent), there can be conditions that place limitations on the individual's right to self determination, which can be especially problematic for [[nonbinary]] individuals. For example, in Germany the Standesamt (Office of Vital Statistics) <ref>http://standesamtauskunft.de/Default2.aspx</ref> typically refuses to recognise in German civil registration law names that are gender-ambiguous; a given name must indicate that the owner is either 'male' or 'female'.

	=====State of Address===== <!--T:22-->		=====State of Address===== <!--T:22-->

imported>TXJ: /* Feminizing hormone therapy */ Typo

2020-11-23T15:23:32Z

Feminizing hormone therapy: Typo

← Older revision		Revision as of 15:23, 23 November 2020
Line 190:		Line 190:
	{{main\|feminizing hormone therapy}}		{{main\|feminizing hormone therapy}}

	Some nonbinary people who were [[sexes#assigned male at birth\|assigned ~~female~~ at birth]] want to look and sound in such a way that most people will see them as women. [[Feminizing hormone therapy]] does this. It is a medicine that a person takes on a regular basis, which makes them go through many of the same changes that women went through at puberty. Some effects of it last only as long as the person takes that medicine, and will go away if they stop, such as looking like a woman (due to skin texture, body odor, tending to have less muscle, and where the body stores fat), and some changes to the genitals and sexual responses. Other effects of this medicine are permanent once they happen, such as growing breasts. Feminizing hormone therapy does not make a person's voice get higher.		Some nonbinary people who were [[sexes#assigned male at birth\|assigned male at birth]] want to look and sound in such a way that most people will see them as women. [[Feminizing hormone therapy]] does this. It is a medicine that a person takes on a regular basis, which makes them go through many of the same changes that women went through at puberty. Some effects of it last only as long as the person takes that medicine, and will go away if they stop, such as looking like a woman (due to skin texture, body odor, tending to have less muscle, and where the body stores fat), and some changes to the genitals and sexual responses. Other effects of this medicine are permanent once they happen, such as growing breasts. Feminizing hormone therapy does not make a person's [[voice]] get higher.

	===Hormone therapy to seem androgynous===		===Hormone therapy to seem androgynous===